Division of Molecular Medicine, Boston Children's Hospital, Harvard Medical School, 3 Blackfan Street, Boston, MA 02115, USA.
Department of Pediatrics, Harvard Medical School, 3 Blackfan Street, Boston, MA 02115, USA.
Science. 2021 Dec 10;374(6573):1353-1360. doi: 10.1126/science.abl9463. Epub 2021 Oct 26.
The Delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has outcompeted previously prevalent variants and become a dominant strain worldwide. We report the structure, function, and antigenicity of its full-length spike (S) trimer as well as those of the Gamma and Kappa variants, and compare their characteristics with the G614, Alpha, and Beta variants. Delta S can fuse membranes more efficiently at low levels of cellular receptor angiotensin converting enzyme 2 (ACE2), and its pseudotyped viruses infect target cells substantially faster than the other five variants, possibly accounting for its heightened transmissibility. Each variant shows different rearrangement of the antigenic surface of the amino-terminal domain of the S protein but only makes produces changes in the receptor binding domain (RBD), making the RBD a better target for therapeutic antibodies.
德尔塔变异株严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)已经取代了之前流行的变异株,成为全球主要流行株。我们报告了其全长刺突(S)三聚体的结构、功能和抗原性,以及伽马和卡帕变异株的结构、功能和抗原性,并将它们的特征与 G614、阿尔法和贝塔变异株进行了比较。德尔塔 S 在较低水平的细胞受体血管紧张素转换酶 2(ACE2)下,能更有效地融合膜,其假型病毒感染靶细胞的速度明显快于其他五个变异株,这可能是其传播性增强的原因。每个变异株的 S 蛋白氨基末端结构域的抗原表面都显示出不同的重排,但只在受体结合域(RBD)产生变化,这使得 RBD 成为治疗性抗体的更好靶标。